Affiliation:
1. N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – branch of National Medical Research Radiological Center of the Ministry of Healthcare of the Russian Federation, Moscow
2. V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs of the Ministry of Healthcare of the Russian Federation, Moscow
Abstract
AAim. To identify factors influencing upon decision on pancreas allograft suitability for transplant and their clinical significance. Materials and methods. We reviewed 95 multiorgan donors under the age of 45, who were considered as pancreas donor between January 2010 and December 2013. 28 pancreata were procured (Group I), 67 pancreata were refused (Group II). Demographic, clinical and laboratory data, anatomical hepatopancreatoduodenal varieties were taken into account. Results. We found that only three factors have an effect on pancreas allograft refusal probability. According to our data, non-transplantation of the liver from the same donor increases the pancreas graft refusal in 4 times. Elevated donor’s sodium and urea blood levels also increase the probability of donor pancreas denial for transplantation. For example, the probability of pancreas graft refusal from the donor with sodium level 145 mmol/l and urea level 6.0 mol/l is only 32%. As compared to the donor with sodium level 160 mmol/l and urea 12.0 mol/l where probability reaches 85%. Other factors: demographic, laboratory, clinical indicators, gepatopancreatoduodenal blood supply variations were not predictive for the procurement decision. Conclusion. Main predictors of pancreas allograft refusal to be taken into account, appropriate correction of donor metabolic disturbances and sufficient experience of the surgeon performing the procurement can increase the availability of pancreas transplantation.
Publisher
V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs
Subject
Transplantation,Immunology and Allergy
Reference13 articles.
1. Got'e SV. Sakharnyi diabet I tipa, diabeticheskaya nefropatiya: vozmozhnosti transplantologii // Vestnik RAMN. 2012; 1: 54–60. Gautier SV. Type 1 diabetes mellitus, diabetic nephropathy: transplantology potential. Annals of the Russian academy of medical science. 2012; 1: 54–60.
2. Peyser T1, Dassau E, Breton M, Skyler JS. The artificial pancreas: current status and future prospects in the management of diabetes. Ann. NY Acad. Sci. 2014 Apr; 1311: 102–123. doi: 10.1111/nyas.12431.
3. Maglione M, Ploeg RJ, Friend PJ. Donor risk factors, retrieval technique, preservation and ischemia/reperfusion injury in pancreas transplantation. Curr. Opin Organ Transplant. 2013 Feb; 18 (1): 83–88.
4. Feng S, Goodrich NP, Bragg-Gresham JL et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am. J. Transplant. 2006 Apr; 6 (4): 783–790.
5. Gruessner RW, Gruessner AC. The current state of pancreas transplantation. Nat. Rev. Endocrinol. 2013 Sep; 9 (9): 555–562.